1. Home
  2. WKHS vs INTS Comparison

WKHS vs INTS Comparison

Compare WKHS & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Workhorse Group Inc.

WKHS

Workhorse Group Inc.

HOLD

Current Price

$5.30

Market Cap

17.4M

ML Signal

HOLD

Logo Intensity Therapeutics Inc.

INTS

Intensity Therapeutics Inc.

HOLD

Current Price

$0.41

Market Cap

24.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WKHS
INTS
Founded
2007
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.4M
24.0M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
WKHS
INTS
Price
$5.30
$0.41
Analyst Decision
Hold
Strong Buy
Analyst Count
1
3
Target Price
$21.00
$4.33
AVG Volume (30 Days)
381.8K
3.2M
Earning Date
11-10-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$10,620,296.00
N/A
Revenue This Year
$92.70
N/A
Revenue Next Year
$34.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
16.73
N/A
52 Week Low
$5.10
$0.19
52 Week High
$139.70
$3.17

Technical Indicators

Market Signals
Indicator
WKHS
INTS
Relative Strength Index (RSI) 64.88 47.25
Support Level $5.10 $0.40
Resistance Level $6.00 $0.43
Average True Range (ATR) 0.87 0.06
MACD -0.01 -0.01
Stochastic Oscillator 41.30 20.02

Price Performance

Historical Comparison
WKHS
INTS

About WKHS Workhorse Group Inc.

Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric delivery trucks and drone systems, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.

About INTS Intensity Therapeutics Inc.

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

Share on Social Networks: